The FDA has approved nivolumab plus chemotherapy as a neoadjuvant treatment for operable stage IIA to IIIB non–small cell ...

The checkpoint inhibitor is now approved, based on CheckMate 77T findings, for neoadjuvant/adjuvant use in patients with resectable NSCLC.

The approval was based on data from the randomized, double-blind, placebo-controlled, phase 3 CheckMate -77T trial.

No benefit seen for rechallenge with nivolumab after progression in the post-immune checkpoint inhibitor setting.

When cancer cells mutate, they produce small peptides called neoantigens.  Because neoantigens remain relatively unique to ...

Illumina, Inc. , a global leader in DNA sequencing and array-based technologies, announced that after 11 years of service, Charles "Chuck" Dadswell will step down as General Counsel and Secretary on ...

Bristol-Myers Squibb (BMY) wins FDA nod to expand the U.S. label for its blockbuster immunotherapy Opdivo in lung cancer.

Today, MedMira Inc. (MedMira) today announced the appointment of Nicole Crenshaw as Vice President of Commercial Operations, effective immediately. Ms. Crenshaw's addition strengthens MedMira's ...

The Food and Drug Administration has approved Opdivo before and after surgery for some with non-small cell lung cancer.

North America Cancer Immunotherapy Market is expanding rapidly due to expanding approval of immunotherapeutic drugs for the treatment of increasing incidences of cancer and increasing investments in ...

CNN anchor Jim Acosta cut short an interview with Corey Lewandowski after he repeatedly mispronounced Vice President Kamala Harris’ name despite being corrected. The discussion grew heated over ...

Sep. 10, 2024 — Phase separation, when molecules part like oil and water, works alongside oxygen diffusion to help memristors -- electrical components that store ... Electrically Modulated Light ...